Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Long-Term Deferred Tax (2017 - 2025)

Historic Long-Term Deferred Tax for Medifast (MED) over the last 9 years, with Q3 2025 value amounting to $12.1 million.

  • Medifast's Long-Term Deferred Tax rose 20254.87% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 20254.87%. This contributed to the annual value of $11.5 million for FY2024, which is 17835.8% up from last year.
  • According to the latest figures from Q3 2025, Medifast's Long-Term Deferred Tax is $12.1 million, which was up 20254.87% from $11.5 million recorded in Q2 2025.
  • In the past 5 years, Medifast's Long-Term Deferred Tax registered a high of $12.1 million during Q3 2025, and its lowest value of $692000.0 during Q1 2021.
  • Its 5-year average for Long-Term Deferred Tax is $5.8 million, with a median of $4.4 million in 2021.
  • In the last 5 years, Medifast's Long-Term Deferred Tax plummeted by 6658.62% in 2021 and then surged by 78872.83% in 2022.
  • Quarter analysis of 5 years shows Medifast's Long-Term Deferred Tax stood at $4.4 million in 2021, then increased by 20.98% to $5.3 million in 2022, then decreased by 22.73% to $4.1 million in 2023, then surged by 178.36% to $11.5 million in 2024, then rose by 5.65% to $12.1 million in 2025.
  • Its Long-Term Deferred Tax stands at $12.1 million for Q3 2025, versus $11.5 million for Q2 2025 and $11.4 million for Q1 2025.